About PT-141 Source

What this site is

PT-141 Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built as a research index: facts first, every claim attributed to a study or to the US prescribing information, and the literature's hedges kept intact rather than smoothed over.

About the word "source"

The domain says "source," and that word is editorial framing, not a service claim. This site is a source of cited summaries — a reading index of the literature. It is not a source of the compound. Nothing here is for sale. We do not link buyers to sellers and we do not list vendors. If you arrived looking to purchase PT-141, this is the wrong site: it indexes studies, not products.

How we handle the evidence

Approved-label facts are flagged as approved. Off-label and investigational uses are flagged as off-label. Unverified community reports are kept visibly separate from cited trial evidence and labeled anecdotal. Disputed findings — such as the 2008 study under a 2023 Expression of Concern — are flagged disputed. We quote the approved label dose as documentation of the approved product, never as a recommendation, and we recommend no dose to any individual.

Corrections

If a citation is misattributed or a figure is wrong, the correction belongs in the record. Use the contact page to flag it. We update the index against the published literature; we do not publish testimonials, dosing guidance, or purchasing information.